Bloom Burton analyst David Martin PhD has maintained their neutral stance on RPTX stock, giving a Hold rating on January 10.Stay Ahead of the ...

Repare Therapeutics Inc. (NASDAQ: RPTX) disclosed significant strategic adjustments in a recent SEC 8-K filing. The precision oncology company declared preliminary unaudited financial data, indicating ...

As top pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Conference next week, biotech ...

Among significant news last week, the US Food and Drug Administration (FDA) required Agios Pharmaceuticals to amend the label ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...